Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference156 articles.
1. Cancer and cardiovascular disease: more tightly linked than by chance;Opie;Lancet (London, England),2015
2. Common risk factors for heart failure and cancer;Meijers;Cardiovasc. Res.,2019
3. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial;Ridker;Lancet.,2017
4. Clonal hematopoiesis confers predisposition to both cardiovascular disease and cancer: a newly recognized link between two major killers;Ebert;Ann. Intern. Med.,2018
5. Age-related clonal hematopoiesis associated with adverse outcomes;Jaiswal;N. Engl. J. Med.,2014
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?;Archiv der Pharmazie;2024-07-29
2. Repurposing of IL 33/ST2 Modulating Drugs as a Cardioprotective Agent: A Promising Approach;Journal of Pharmaceutical Innovation;2024-02-20
3. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024
4. Insights Into Antioxidant Strategies to Counteract Radiation-Induced Male Infertility;Antioxidants & Redox Signaling;2023-12-22
5. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies;Cancer Cell International;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3